Warfarin prescribing in atrial fibrillation (AF) was significantly improved with an educational programme

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1470, 2005-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Barriers to warfarin use in atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Warfarin use suboptimal in new-onset atrial fibrillation

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 427, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Predictors of Warfarin Use in Atrial Fibrillation Patients in the Inpatient Setting

By Agarwal Shuchita  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 37-48

Adis International

Access to resources Recommend Favorite

Warfarin in the Secondary Prevention of Thromboembolism in Atrial Fibrillation: Impact of Bioavailability on Costs and Outcomes

By Nicole Mittmann   Paul I. Oh   Scott E. Walker   William R. Bartle  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 671-683

Adis International

Access to resources Recommend Favorite

Identifying Temporal Changes to the Prescribing of Anti‐Arrhythmics for Atrial Fibrillation

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 4, 2010-12 ,pp. : 285-289

John Wiley & Sons Inc

Access to resources Recommend Favorite